PLN 150 Million for Biotech R&D: NCBR Launches FENG Call for Polish Enterprises

PLN 150 Million for Biotech R&D: NCBR Launches FENG Call

The National Centre for Research and Development (NCBR) is inviting Polish enterprises and research consortia to tap into a substantial funding pool for biotechnology research and development projects. Under the FENG program (Fundusze Europejskie dla Nowoczesnej Gospodarki - European Funds for a Modern Economy), this call allocates PLN 150 million to drive innovation in one of the most dynamic and high-impact sectors of the Polish economy.

What’s on Offer?

This is not a small-scale opportunity. The minimum project value ensures that only substantive, ambitious initiatives will be considered. For companies or consortia that have a promising biotech concept ready to move from the lab toward market readiness, this call could be the catalyst that accelerates your timeline by years.

Who Should Apply?

The call is open to:

Because the minimum funding request is PLN 7 million, the NCBR expects projects that are comprehensive and have clear commercial potential. Applicants should already have a strong proof of concept or early-stage prototype and be ready to scale up development activities.

Why Biotechnology?

Biotechnology is a cornerstone of the modern economy, with applications spanning:

Poland has a growing ecosystem of biotech startups and established companies, but access to scale-up funding remains a barrier. This NCBR call is designed to bridge that gap by co-financing projects that can move from research to demonstration and pilot stages, ultimately leading to new products, services, or processes.

Practical Tips for Deciding Whether to Apply

1. Check eligibility requirements carefully

2. Align your project scope with the call’s expectations

3. Prepare a realistic budget

4. Build a strong team

5. Understand the timeline

6. Leverage existing resources

How to Prepare a Strong Application

A. Define the problem and solution clearly

The evaluators need to see a clear unmet need - whether in healthcare, industry, or environment - and how your innovation addresses it. Use data, pilot studies, or literature to back your claims.

B. Show a credible work plan

Break the project into logical work packages (WPs) with deliverables, milestones, and timelines. Include risk mitigation strategies, especially for technical risks common in biotech (e.g., low yields, regulatory hurdles).

C. Demonstrate commercial potential

A great R&D project without a market path may be rejected. Include:

D. Plan for dissemination and exploitation

NCBR expects that results will be used. Describe how you will protect, publish, or commercialise results. Consortia should clarify which partner exploits which results.

E. Double-check administrative requirements

The Bigger Picture: Why FENG?

FENG is the successor to the Intelligent Development Operational Programme (POIR) and represents Poland’s main instrument for supporting innovation from EU funds for the 2021-2027 period. The programme focuses on:

By targeting biotechnology specifically, this call acknowledges the strategic importance of life sciences for future economic resilience. The PLN 150 million pool is a strong signal that NCBR is willing to back high-risk, high-reward projects.

How GrantGunner Can Help

On GrantGunner, you can:

Start by visiting the Apply URL listed in the call details to download the official documentation. Then use GrantGunner’s tools to track your progress, manage deadlines, and align your proposal strategy with funder expectations.

Final Thoughts

The NCBR biotechnology call is a major opportunity for Polish enterprises to secure meaningful public co-financing for R&D that can transform ideas into market-ready innovations. With PLN 150 million available and individual project support ranging from PLN 7 million to PLN 140 million, this is not a routine grant - it’s a strategic investment in your company’s future.

Don’t wait until the 2026 opening date. Begin internal discussions, identify partners, and refine your concept today. The difference between a successful application and a rejected one often lies in the preparation months before the deadline.

For full details, including eligibility conditions, application forms, and evaluation criteria, always refer to the official source linked below. And for your daily dose of funding intelligence, keep GrantGunner in your corner.


Disclaimer: The information provided in this article is based on the available research brief. Requirements may change; always verify with the official call documentation.

Draft the next application in GrantGunner

Create a free account, add your documents, and draft the form with your team. Create a free account

More from the GrantGunner blog